A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Condition:   Attention Deficit Disorder With Hyperactivity Interventions:   Drug: Methylphenidate;   Drug: Lisdexamfetamine;   Drug: Atomoxetine;   Drug: Amphetamine;   Drug: Dextroamphetamine Sponsor:   Janssen Research & Development, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials